Cite

HARVARD Citation

    Tacconi, E. et al. (2019). Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance. EMBO molecular medicine. 11 (7), p. n/a. [Online]. 
  
Back to record